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ABSTRACT 
 
 
 
 
RNA molecules are transcribed as single stranded naturally, but with most of them 
forming in to structures composed of duplex regions, loop, bulge or mismatches. RNAs with 
double stranded regions, or known as double-strand RNAs (dsRNAs). The class of proteins 
responsible for processing dsRNAs is termed double-stranded RNA binding proteins (dsRBP). 
In recent decades, an increasing number of reports have shown the role of dsRBP-dsRNA 
interaction as core strategy in various cellular regulation pathways, including RNA interference, 
anti-viral immunity, mRNA transport and alternative splicing. However, little is known about 
the molecular mechanisms underlying the interaction between dsRBPs and dsRNA.  
 
Here we examined four human dsRBPs, ADAD2, TRBP, Staufen 1 and ADAR1 
`which have various numbers of RNA binding domains expressed in mammalian cells. We 
applied single molecule pull-down (SiMPull) assay to investigate the intensity of various 
dsRNA-dsRBP interactions. Our results demonstrate that despite the highly conserved dsRNA 
binding domains, the dsRBPs exhibit diverse substrate specificy. While TRBP and ADAR1 
have a preference for binding simple duplex RNA, ADAD2 and Staufen1 display higher affinity 
to imperfectly base-paired structured RNA substrates. We also demonstrate ATP-independent 
sliding activity of TRBP and Staufen probed by single molecule protein induced fluorescence 
enhancement (smPIFE), which demonstrates how single molecule approaches could be utilized 
to provide new insight into molecular mechanisms involved in protein-RNA interaction. 
Collectively, our study highlights the diverse nature of substrate specificity exhibited by dsRBPs 
that may be critical for their cellular function. 
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CHAPTER 1 
INTRODUCTION 
 
 
1.1 Background  
While all cellular RNA molecules are synthesized in single-stranded (ss) form, many 
can form into secondary structures that encompass segments of double stranded (ds) RNA. 
Hence, dsRNA molecules are common in cells and are recognized as critical regulatory factors 
in many biological processes (1-3). For example, dsRNA regions are present in the precursors of 
microRNAs, siRNAs, messenger RNA (mRNA), transfer RNA (tRNA), as well as in the 
genome of RNA viruses that can be released into cells upon infection.  
 
The family of proteins responsible for processing dsRNA is called double stranded 
RNA binding proteins (dsRBP). In recent decades, an increasing number of reports have shown 
the employment of dsRBP-dsRNA interaction as core strategy in various cellular regulation 
pathways, including RNA interference, anti-viral immunity, mRNA transport and alternative 
splicing. Various dsRNAs serve as cargoes, activators and substrates of dsRBPs to carry out the 
function of this protein family (4,5). For example, certain dsRNA structures found in viruses 
activates protein kinase R (PKR), which in turn triggers the downstream antiviral immune 
pathways (6,7); pri-microRNAs are recognized and cleaved by Drosha-DGCR8 to produce pre-
microRNA in the nucleus, which then get exported into cytoplasm and cleaved by Dicer-TRBP 
to transform into matured microRNA (8,9).  
  
The dsRBP family is defined by the presence of one or more double-stranded RNA 
binding domains (dsRBD) (10). The dsRBDs are highly conserved in amino acid composition 
and domain structures and have been identified across various species (11-13). Despite the high 
degree of domain conservation, dsRBPs are involved in diverse biological functions where they 
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interact with variety of RNA substrates, which vary in secondary structure and differ in length 
of duplex. While the biological functions of dsRBPs are known, it remains uncertain if dsRBPs 
exhibit certain substrate specificity.  
 
Two types of dsRBDs are found in dsRBPs; type-1 dsRBD (dsRBD-I) usually binds 
dsRNA while type-2 (dsRBD-II) is mainly involved in protein-protein interaction (10,14). The 
number of dsRBD-I present in each dsRBP is highly variable (5); for instance, while both  
function as RNA deaminase, ADAD2 contains only one dsRBD-1, whereas ADAR1 contains 
three. It is heretofore unknown why some dsRBPs need multiple units while others possess a 
single dsRBD-I, and if the number of the dsRBD-I is correlated with the protein’s affinity to 
dsRNA. dsRBD-I adopts an “α-β-β-β-α“ structure, which contacts dsRNA in three grooves 
(minor-major-minor) along a stem spanning 15 base pairs (bp) (11,12). This protein-RNA 
binding mode is structure- but not sequence-dependent since dsRBDs recognize the A-form 
helical axis of dsRNA rather than the specific RNA sequence (4,15). While dsRBD-I of ADAR2 
recognizes and binds dsRNA at certain mismatch locations (16), it is not clear to what extent 
other dsRBDs contribute to binding dsRNA and imperfectly base-paired structured dsRNA.  
 
 
1.2 Thesis organization 
To address some of these outstanding questions, we examined dsRNA interaction with 
four dsRBPs: ADAD2, TRBP, Staufen1 and ADAR1. We chose dsRBPs that contain different 
number of dsRBD-I units and participate in various cellular functions. ADAD2 has only a single 
dsRBD-I, followed by Staufen1 and TRBP containing two, and ADAR1 possessing three units 
of dsRBD-Is. In terms of biological function, both ADAD2 and ADAR1 are RNA deaminases 
that edit adenosine to inosine (A to I) in mRNA and microRNA precursors (17). Staufen1 is 
responsible for mRNA transport to dendrites in neurons where its fourth dsRBD likely binds 
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microtubules along axons (18). In addition, human Staufen1 binds to the 19bp stem in ARF1 
mRNA and also to intermolecular Alu element-Alu element duplexes for the purpose of 
Staufen-mediated mRNA decay (SMD)(19)(20); and intramolecular Alu element-Alu elemenr 
duplexes to compete with mRNA retention in paraspeckles (21). TRBP is a key player in the 
RNA Induced Silencing Complex (RISC) assembly (22) and also modulates the initiation of 
HIV-1 gene expression (23,24).  
 
We investigated the binding affinity of the four dsRBPs toward six different dsRNA 
substrates with varying length of duplex and secondary structures. The length variants include 
25bp, 40bp, and 55bp dsRNA whereas the imperfectly base-paired structured RNA includes pre-
let7 (pre-microRNA), TAR RNA and tRNA. All proteins were overexpressed in mammalian 
cells (HEK 293) and pulled down to a single molecule imaging surface coated with the 
appropriate antibody (25). Fluorescence-labeled RNA substrates were added to test their binding 
affinity. Our study reveals that despite the presence of highly conserved dsRNA binding 
domains, the dsRBPs investigated display substantial differences in their substrate specificity on 
RNA substrates.  
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CHAPTER 2 
METHODOLOGY 
 
 
 
2.1 RNA labeling and annealing 
The sequences of all RNA substrates are displayed in Table S1. Pre-let7, TAR and 
tRNA molecules were purchased from IDT as single strand RNA with fluorescent label at the 5’ 
end. 25bp, 40bp and 55bp dsRNAs were purchased from Dharmacon as separate single strand 
RNA and 3’-DY547 was incorporated in the process of each RNA synthesis.  
For dsRNA annealing, two complementary RNA strands were mixed in equal 
concentration in annealing buffer (100mM NaCl and 10mM Tris at pH 8) and heated at ~90°C 
for 2 min and gradually cooled to room temperature. U40 with 3’ amine modification was 
purchased from IDT and labeled with Cy3 NHS ester dye from GE Healthcare1. Briefly, the dye 
was mixed at two-fold molar excess concentration with RNA containing 3' amine modifier, in a 
buffer containing 100mM NaHCO3 at pH 8.5 and then incubated overnight. Unreacted dye was 
removed by two rounds of ethanol precipitation. The resulting labeling efficiency was about 
90%.  
 
 
2.2 Protein lysate preparation 
ADAD2, TRBP, and Staufen1 were cloned from Human Open Reading Frame 
Library and a C-terminal EYFP was added to each protein sequence. Then, C-terminal EYFP-
TRBP, C-terminal EYFP-Staufen1 and N-terminal EGFP-ADAR1 were overexpressed in 
human A549 cells, and C-terminal EYFP-ADAD2 was overexpressed in HEK293 cells. Cells 
were lysed using RIPA (Thermo Scientific RIPA Lysis and Extraction Buffer, Catalog number: 
89900) 24 hours after transfection and cell lysates were collected and centrifuged; finally 
supernatants were collected for each protein. Cell lysates were stored in -80°C for later use.  
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2.3 Lysate protein concentration measurement  
To measure the concentration of EYFP/EGFP tagged proteins and normalize them to 
the same level on single molecule surface, following things have been done. First, we used 
commercial cy5 dye with known concentration measured by spectrophotometry and did a serial 
dilution with cy5 and measure the corresponding fluorescent intensity with fluorometry at each 
diluted concentration to produce a standard concentration-fluorescent intensity line.  
And then we measured the fluorescent intensity of the four dsRBPs in lysate with 
either EGFP or EYFP tags by fluorometry and normalized the intensity using extinct coefficient, 
quantum yield and absorption percentage at specific excitation wavelength of EGFP and EYFP, 
respectively to get the normalized fluorescence of each protein lysate. And we plot the 
normalized fluoresence along the standard concentration-fluorescent intensity line to read 
concentration for each individual lysate sample. 
 
 
2.4 Single molecule pull down assay (SiMPull) 
Polyethylene glycol (PEG)-coated quartz slides with flow chambers were obtained 
according to previously published protocol 2. A PEG surface was coated with Neutravidin 
(0.05mg/mL) followed by anti-GFP (RABBIT, 5µg/ml) antibody conjugated with biotin 
(Rockland 600-406-215) and incubated for another 5min in T50 (10 mM Tris pH 8 and 50 mM 
NaCl). About 400pM of C-terminal EYFP or N-terminal EGFP fused dsRBP cell lysates were 
added to the antibody coated surface and incubated for 5-10min.  
To measure the level of dsRBPs on the PEG surface, we used the level of TRBP-
EYFP as standard for all dsRBPs, since the concentration of four dsRBPs were calibrated and 
dilution factors were normalized to make sure they were applied at the same level on the PEG 
surface. To measure the level of TRBP after SM Pull-down using biotinylated GFP antibody, 
we used anti-TRBP antibody (Abcam [1D9](ab129325)) and Anti-mouse Alexa Fluor® 488 
Conjugate (Cell Signaling #4408).  
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2.5 Tables 
 
Table 2.1. 
Name	   Sequence	  
25bp	  RNA	   5’-­‐	  rGrCrUrUrGrUrCrGrGrGrArGrCrGrCrCrArCrCrCrUrCrUrGrC-­‐3’	  (up)	  
	   5’-­‐	  rGrCrArGrArGrGrGrUrGrGrCrGrCrUrCrCrCrGrArCrArArGrC-­‐DY547-­‐3’	  (down)	  
	   	  
40bp	  RNA	   5’-­‐	  rGrCdTrUrArArCrArArCrCrArGrArUrCrArArArGrArArArArArArCrArGrArCrArUrU	  
	  	  	  	  	  	  rGrUrCrA-­‐3’	  (up)	  
	   5’-­‐	  rUrGrArCrArArUrGrUrCrUrGrUrUrUrUrUrUrCrUrUrUrGrArUrCrUrGrGrUrUrGrU	  
	  	  	  	  	  	  rUrArArGrCrGrU-­‐DY547-­‐3’	  (down)	  
	   	  
55bp	  RNA	   5’-­‐	  rArCrGrCrUrUrArArCrArArCrCrArGrArUrCrArArArGrArArArArArArCrArGrArCrA	  
	  	  	  	  	  	  rUrUrGrUrCrArArUrUrGrCrArArArGrCrArArArArA-­‐3’	  (up)	  
	   5’-­‐	  rUrUrUrUrUrGrCrUrUrUrGrCrArArUrUrGrArCrArArUrGrUrCrUrGrUrUrUrUrUrU	  
	  	  	  	  	  	  rCrUrUrUrGrArUrCrUrGrGrUrUrGrUrUrArArGrCrGrU-­‐DY547-­‐3’	  (down)	  
	   	  
Pre-­‐let7	   5’-­‐	  cy3-­‐rUrGrArGrGrUrArGrUrArGrGrUrUrGrUrArUrArGrUrUrUrUrArGrGrGrUrCrArCrA	  
rCrCrCrArCrCrArCrUrGrGrGrArGrArUrArArCrUrArUrArCrArArUrCrUrArCrUrGrUrCrU
rUrArCrC-­‐3’ 
	   	  
TAR	   5’-­‐cy3-­‐rGrGrUrCrUrCrUrCrUrGrGrUrUrArGrCrCrArGrArUrCrUrGrArGrCrCrUrGrGrGrA	  
rGrCrUrCrUrCrUrGrGrCrUrArArCrUrArGrGrGrArArCrC-­‐3’ 
	   	  
tRNA	   5’-­‐cy3-­‐	  rGrGrGrArArGrCrCrCrGrGrArUrArGrCrUrCrArGrUrCrGrGrUrArGrArGrCrArUrC	  
rArGrArCrUrUrUrUrArArUrCrUrGrArGrGrGrUrCrCrArGrGrGrUrUrCrArArGrUrCrC 
rCrUrGrUrUrCrGrGrGrCrGrCrCrA-­‐3’ 
	   	  
PolyU40	   5’	  –rUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrUrU	  
rUrUrUrUrUrU-­‐cy3-­‐3’ 
 
Table 2.1. Sequences of dsRNA substrates involved in interaction with dsRBPs.  
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CHAPTER 3 
RESULTS 
 
 
 
3.1 Single molecule pull down (SiMPull) of dsRBPs 
Four dsRBPs, ADAD2, TRBP, Staufen1 and ADAR1 were chosen because they all 
have at least one dsRBD-I (type I dsRBD) with highly conserved amino acid residues (Figure 
3.1 A and B). However, the dsRBPs differ in total length (600 to 1,500 amino acids) as well as 
in overall domain composition. ADAD2 and ADAR1 possess a large deaminase domain 
whereas TRBP and Staufen1 encompass dsRBD-II (type II dsRBD) domains (Figure 3.1 A). We 
sought to set up a single molecule affinity testing platform in which one can immobilize the 
same number/density of dsRBP and apply same amount of RNA substrates with varying 
structures.  To achieve this, we first need to normalize the concentration of expressed dsRBPs, 
followed by single molecule pull-down assay (25) to isolate dsRBPs directly from mammalian 
cells.  
 
To normalize the concentration of these four proteins, we did following things First 
the full length of each dsRBP fused with an EYFP or EGFP tag was over-expressed in HEK293 
cells (Figure 3.1 A). The cell lysate was obtained and the intensity of EYFP/EGFP was imaged 
by confocal microscope to test the dsRBP expression level. Second, we used commercial cy5 
dye with known concentration measured by spectrophotometry (Figure 3.2 A) and serially 
diluted this cy5 dye to measure the corresponding fluorescent intensity by fluorometry to 
produce a standard concentration-fluorescent intensity line (Figure 3.2 B). And then we 
measured the fluorescent intensity of the four dsRBPs with either EGFP or EYFP tags by 
fluorometry and normalized these fluorescent intensity using extinct coefficient, quantum yield 
and absorption percentage at specific excitation wavelength of EGFP and EYFP, respectively. 
8  
And we plot the normalized fluorescence of these four dsRBPs along the standard 
concentration-fluorescent intensity line (Figure 3.2 B) to read each individual concentration. 
 
Upon determining the concentration of each protein based on the fluorescence intensity 
of EYFP/EGFP, the same concentration of each dsRBP was applied on a single molecule 
surface coated with anti-GFP/anti-YFP antibody (24) (Figure 3.3 A). The specificity of dsRBP 
binding to the surface was confirmed by adding serially diluted cell lysate to anti-GFP coated 
surface and applying primary and fluorescence (A488) labeled secondary antibody for the 
corresponding dsRBP, where we used TRBP lysate as an example (Figure 3.3. B). We 
confirmed the dsRBP binding specificity and obtained an accurate count of TRBP molecules on 
the surface and the number of countable TRBP molecules on the surface was saturated as the 
concentration of cell lysate increased (Figure 3.3 C). And this also provided us the level of total 
individual dsRBP on surface, which is critical to obtain the ratio of dsRBP bound by dsRNA in 
the experiments afterwards. 
 
3.2 Relative binding affinity of dsRBPs to various RNAs 
To investigate the RNA binding specificity of the four dsRBPs, Cy3-labeled RNA 
molecules were applied to the dsRBP-immobilized imaging surface (Figure 3.4 A). The 
fluorescence of EYFP or EGFP on dsRBPs does not interfere with the detection of Cy3 signal 
due to the extremely fast photobleaching of both fluorescent proteins. The RNA substrates that 
differ in duplex length and secondary structure were prepared. The length variants, 25bp, 40bp 
and 55bp dsRNA were categorized as “non-structured” and the structure variants, pre-let7, 
TAZR and tRNA as “structured” RNA (Figure 3.4 B). We note that all structured RNA still 
retained a long dsRNA stem sufficient for dsRBP binding (Figure 3.4. C). The single strand (ss) 
RNA composed of 40-uracil (U40) was included as a negative control.  
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After checking the density of dsRBP molecules on the imaging surface, we applied 
Cy3 labeled RNA, washed out the unbound RNA and visualized the fluorescence signal by 
home-built total internal reflection fluorescence (TIRF) microscope (Figure 3.4 A). The single 
molecule images from multiple areas were taken to count the number of dsRNA bound to 
proteins on the surface. For each RNA interaction case, the average number of RNA bound per 
field of view was used as a proxy for the comparative binding affinity of the corresponding 
RNA-dsRBP pair. The nonspecific binding of dsRNA was checked by omitting cell lysates and 
by applying a negative control, U40 ssRNA. Both showed negligible binding, suggesting that 
the fluorescence signals arise from the specific binding of dsRNA to dsRBP molecules (Figure 
3.6A). 
 
Taking TRBP as an example, we further confirmed that the overexpressed dsRBPs are 
interacting with applied dsRNAs on themselves without any other collaborator or protein 
complex, and that the terminal EGFP/EYFP tagging would not affect dsRBPs binding to dsRNA 
substrates (Figure 3.5 A and B). We fixed the concentration of applied dsRBPs from lysate at 
around 300pM. At this concentration, we verified that Staufen1 would exist dominantly as 
monomer (Figure 3.5 C) (27). Due to limitation of bulk measurement, previous literature mostly 
focused on function of Staufen1 homodimer, hence single molecule pull down provides us a 
unique approach to study the activity of monomer Staufen1. 
 
 We quantified the fraction of RNA-bound dsRBP to total dsRBP molecules (sum of 
bound- and unbound molecules) for each dsRBP with six dsRNAs and one ssRNA. Amongst the 
four dsRBPs, TRBP showed the highest relative binding affinity to all substrates, mostly 
ranging between 80 to 90%, except for the reduced binding to tRNA (~50%). Staufen1, ADAR1, 
and ADAD2 exhibit substantially lower affinities to all RNAs in general; on average, 20%-40% 
of protein was occupied by RNA (Figure 3.4 C). Notably, the comparative binding affinities of 
dsRBPs toward RNA are not correlated with the number of dsRBD-I. For instance, ADAR1 
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with three dsRBD-Is and ADAD2 with only one dsRBD-I displayed similar binding affinities 
for RNA substrates whereas TRBP with two dsRBD-Is exhibited the highest affinity. Together, 
our data indicates that the number of type-1 dsRBDs is not a major factor for determining 
dsRBP-dsRNA affinity.  
 
To test if TRBP alone is primarily responsible for binding dsRNA, we performed 
EMSA where we subjected three Cy3 labeled dsRNA substrates to both TRBP overexpressed 
cell lysate and purified TRBP. The result shows that TRBP-RNA complex from both are 
comparable (Figure 3.5 A and B). This also confirms that the EYFP tagging does not interfere 
with dsRNA binding (43). Together, our data indicates that the number of type-1 dsRBDs may 
not be a major factor for determining dsRBP-dsRNA affinity. In agreement with previous report 
(44, 45), Staufen1 interacts with itself at high concentration range (>100 nM) as shown by 
EMSA assay (Figure 3.5 C).  
 
The four dsRBPs also displayed different binding affinities to various structural 
features of RNAs. To compare the binding propensity toward structured RNA, we obtained the 
average of all bound fractions corresponding to structured (pre-let7, TAR and tRNA) and non-
structured RNA (25, 40 and 55 bp) substrates for each dsRBP (Figure 3.4 C) and calculated the 
ratio between structured versus non-structured (S/N), termed here affinity ratio (Figure 3.4 D); 
ratio of 1 indicates no bias to either type whereas a ratio >1 reflects a preference toward 
structured RNAs. Interestingly, ADAD2 and Staufen1 showed significantly higher affinity for 
the structured RNAs with the affinity ratio approaching 2:3 (Figure 3.4 D). On the other hand, 
TRBP and ADAR1 have similar affinities for almost all the RNA substrates (Figure 3.4 D). 
Unexpectedly, all the proteins displayed substantial affinity to highly structured tRNA-like RNA, 
which can be in part due to tRNA, which has a complex L-shape with only a short dsRNA 
portion of 13–14 bp and the mixed population of misfolded RNA. (46) 
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To further test the binding of tRNA, we performed two types of competitive binding 
assays. First, we applied equimolar concentration of Cy3 labeled tRNA and Cy5 labeled 27bp 
dsRNA to single molecule surface coated with individual dsRBPs. We observed that the binding 
affinity and preference for tRNA versus dsRNA exhibited the same pattern as our previous 
assay shown in Figure 3C b  (Figure 3.6 B). This result confirms that tRNA binds to dsRBPs, 
albeit to varying degrees and that Staufen1tossay shown in Figur for structured RNA is retained 
even in the presence of dsRNA. Second, we added tRNA to dsRBPs pre-bound with dsRNA and 
observed that tRNA still exhibited sufficient level of competitive binding (Figure 3.6 C). 
Furthermore, dsRBD–tRNA binding model is plausible: in one possible binding mode, dsRBD2 
of TRBP fits in the duplex-like region of tRNA, and the contact area between dsRBD and tRNA 
is comparable to values observed for regular dsRNA, even slightly higher, as the ssRNA tail of 
tRNA can also bind to the dsRBD on the side (Figure 3.6 D).  
 
In conclusion, the four tested dsRBPs exhibit different substrate specificities in our 
single molecule platform, which may arise from different binding affinities toward RNA 
substrates with varying secondary structures. Furthermore, RNA binding affinity of dsRBP does 
not seem to depend on the number of its dsRBD-I. 
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3.3 Figures 
 
 
Figure 3.1. Single molecule pull down of four dsRBPs.  
A) Functional domains of four dsRBPs. ADAD2, TRBP2 and Stau1 were fused with EYFP at C-terminal, 
while ADAR1 was fused with GFP at N-terminal.  
B) Amino acid sequence information of the type-1 dsRBDs in ADAD2, TRBP2, Stau1 and ADAR1. Top 
line shows the consensus residues of dsRBDs, which are highlighted in yellow shade. Second line shows 
the key residues critical for folding into dsRBD conserved αβββα structure. The third line shows the 
residues necessary for dsRNA binding, of which the font color is red. Secondary structure α-β-β-β-α 
sections are labeled out, together with dsRNA binding regions. 
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Figure 3.2. Characterization of four dsRBPs concentration from cell lysate.  
A) Spectrophotometry absorption measurement of free Cy5 dye sample.  
B) Determination of dsRBP concentration based on the calibration curve generated from Cy5 dye. Cy5 
dye sample was serially diluted to generate a standard fluorescence-to-concentration line. Plotting 
normalized fluorescence intensity of four dsRBPs from lysate onto the calibration line enables estimation 
of concentration for each dsRBPs in lysate.  
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Figure 3.3. Single molecule pull down of normalized dsRBP lysate.  
A) Schematic explanation for single molecule pull down of dsRBP from cell lysate using biotinylated 
antibody against EYFP/GFP onto bio-PEG coated surface, with non-specific protein being washed away. 
B) Measurement of TRBP level on single molecule surface using primary and Alexa488 labeled 
secondary antibody against TRBP. Control experiment showed the non-specific binding of TRBP, 
primary or secondary antibody.  
C) Quantification of number of fluorescent spot from the right most panel in B) for increasing lysate 
amount, with the count saturated at highest lysate amount we tested.  
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Figure 3.4. Relative binding affinity of dsRBPs to various dsRNAs.  
(A) Schematic illustration of fluorescence labeled dsRNA bound by dsRBP on the PEG- coated surface. 
1 nM dsRNAs were used in all cases.  
(B) Secondary structure of six dsRNAs tested and the ssRNA of U40 tested as a negative control. 
Regions marked by red dotted circles involve a set of minor–major–minor grooves, which suffice for one 
dsRBD interaction with dsRNA.  
(C) The relative binding affinity of each dsRBP to six dsRNAs shown in Figure 3B. The fraction was 
calculated as the ratio of the number of dsRNA molecule measured by cy3 detection and the number of 
dsRBP molecules detected by immuno-fluorescence measurement against EYFP/GFP at single molecule 
level.  
(D) dsRBP preference to structured or non-structured dsRNA in terms of relative binding affinity. The 
categories of structured and non-structured RNA are shown in (B). 
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Figure 3.5. Characterization of protein purity and dimer/monomer status from cell lysate.  
A) EMSA assay to test the affinity of TRBP_YFP from lysate vs. purified TRBP to three representative 
RNA substrates labeled with Cy3 labeled.  
B) Quantification of shifted protein-RNA complex bands in A).  
C) EMSA assay to test concentration dependent oligomerization of purified Staufen1 interacting with 
Cy3-tRNA in parallel with Staufen1 lysate.  
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Figure 3.6. Nonspecific binding test and competitive binding affinity of dsRBPs towards tRNS vs. 
dsRNA  
A) Testing nonspecific binding by omitting cell lysate, pre-let7 RNA and adding U40 ssRNA.  
B) Competitive binding assay between duplex Cy3-tRNA and Cy5-dsRNA (27 bp) on single molecule 
platform by applying the same concentration (500pM each) of the two RNAs at each of the four dsRBPs 
immobilized surface.  
C) Competitive binding assay in which dsRNA pre-bound to dsRBP was competed away by labeled 
tRNA (gray bar). The tRNA binding result is put in as a comparison (black bar). The tRNA was able to 
compete against dsRNA to sufficient degree for all four proteins tested.  
D) MD simulation of dsRBD2 of TRBP to binding to dsRNA vs. tRNA. The interaction to tRNA is 
comparable to dsRNA. 
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CHAPTER 4 
DISCUSSION 
 
 
 
 
4.1 Protein–RNA interaction examined by single molecule fluorescence 
The functions of dsRBPs are implicated in diverse cellular pathways including micro 
RNA, RNA editing, antiviral signaling, mRNA transport and alternative splicing. We sought to 
profile a set of dsRBPs in binding specificity of dsRBPs to different lengths and structures of 
dsRNAs that are relevant to cellular RNAs. The single molecule pull-down assay enabled us to 
measure the relative affinity of dsRNA substrates toward dsRBP. This platform provides several 
main advantages over other methods such as electrophoretic mobility shift assay (EMSA). The 
proteins can be directly pulled down from cell lysate without being processed through 
purification steps, hence preserving the native context of the protein in cells. Second, it enables 
one to detect not only stable binding but also weak or transient binding events, which is not 
possible with gel-based assays. Third, it allows observation of single dsRBP-dsRNA interaction 
with unlabeled protein to avoid potential disruption by the fluorescent dye that may perturb the 
protein activity. 
 
 
4.2 dsRBPs’ binding affinity to dsRNAs varies despite highly conserved dsRBD 
There are ∼30 known dsRBD-containing proteins in human cells. Most of the 
dsRBDs, including dsRBD1 and dsRBD2 of TRBP, dsRBD2 of Staufen1 and dsRBD3 of 
ADAR1, possess the canonical dsRNA binding motifs that contact the minor–major–minor 
pattern on A-form dsRNA helix. One exception is ADAD2 dsRBD, which is missing one K 
residue from the KKxxK motif and the H residue on the loop connecting _1 and _2 strands. The 
loop contains only hydrophobic residues, making it unlikely to form hydrogen bond contact with 
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the minor groove of dsRNA. The lack of K and H amino acids make ADAD2 dsRBD 
interactions with dsRNA substantially weaker than for other dsRBDs. In agreement, we 
obtained the lowest overall binding affinity of ADAD2 to all types of RNAs tested (Figure 3.4 
C). On the other hand, dsRBD3 of ADAR1 has all the consensus dsRBD residues, yet ADAR1 
exhibits weak binding to most RNAs tested, which is possibly due to the fact that ADAR1 
represents a relatively large protein. Taken together, the structural model analysis and relative 
affinity results suggest that the binding affinity of dsRBP to dsRNA may be correlated to the 
predicted binding affinity of single dsRBDs in some cases, but not in all cases. 
 
Our binding affinity results indicate a plausible distinction between the strong (TRBP) 
and weak binders (all others) to dsRNA, although most of the dsRBDs contain all the dsRNA 
binding consensus residues (besides ADAD2 and Staufen1-dsRBD3). A possible reason for this 
discrepancy in RNA binding strength might be the presence of a basic residue adjacent to the 
KKxxK motif (either K or R) observed in several dsRBDs. Alternatively, other structural 
features in ADAD2, ADAR1 and Staufen1 proteins can modulate their dsRNA binding and 
dynamic properties; for example, dsRBDs could be sterically occluded from interacting with 
RNA, have competitive binding to other protein do- mains, or require dimerization for high-
affinity binding to dsRNA. In fact, ADAR1 is known to bind to 19-bp siRNA with high affinity 
in the dimer form (Kd = 0.21 nM), or with lower affinity when dimerization is prevented due to 
a single mutation (Kd = 2.2 nM) (51). 
 
4.3 Number of dsRBDs may not correlate with the RNA binding 
 
 
It is interesting and puzzling that the number of type-1 dsRBD per protein is highly 
variable in the dsRBP family, ranging from one to five. It is not known if the number of 
dsRBDs determines its binding strength to dsRNA or if they contribute to substrate specificity 
of the dsRBP. We characterized four dsRBPs with a different number of dsRBDs. Our data 
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shows that the binding affinity of dsRBPs toward RNA substrates is not necessarily correlated 
with the number of dsRBD-Is (Figure 3.1 A). ADAR1 with the highest number (3) of dsRBD-Is 
did not show the highest affinity whereas TRBP with only two dsRBD-Is exhibited the strongest 
affinity to all substrates. Our data also indicates that the number of dsRBDs may not contribute 
to binding preference to structured versus unstructured dsRNA or to length of dsRNA. For 
instance, ADAR1 with three dsRBDs showed the least variance in binding affinity toward 
studied RNA substrates, while Staufen1 with two dsRBDs showed preferred binding to 
structured RNA (Figure 3.4 D). We conclude that multiple dsRBDs may not be responsible for 
discriminating dsRNA length or structure on their own. We note that our conclusion is based on 
the sub- set of structural variants chosen for this study and may not reflect a situation in cells. 
 
Based on the experimentally determined Kd values for dsRNA binding to several 
TRBP and ADAR1 constructs (49,51), we can further examine the effect of multiple dsRBDs on 
protein–dsRNA binding strength (Figure 3.6 D). The Kd values of TRBP–dsRBD2 and TRBP–
dsRBD1 are 113 and 220 nM (49), respectively, indicating that TRBP–dsRBD2 has stronger 
binding to dsRNA. These Kd values can be used to estimate a lower bound on the Kd value of 
the TRBP–RBD1+2 construct, in which TRBP–RBD1 and TRBP–RBD2 are linked by a long 
flexible linker of 61 amino acids. If we assume that the dsRBDs act independently when flexibly 
bound, we can predict the Kd by obtaining a product of Kd values of individual dsRBDs (Figure 
3.6 D). However, the experimental Kd value of TRBP–RBD1+2 (250 pM) is an order of 
magnitude higher than the theoretically estimated lower-bound Kd (24.9 pM), which indicates 
that dsRBDs are not completely independent of each other in TRBP. Therefore, the presence of 
multiple dsRBDs in a protein is likely to strengthen protein–dsRNA binding and lower the Kd 
value, but not to the strongest possible binding associated with the predicted lower-bound Kd 
value. 
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CHAPTER 5 
CONCLUSION 
 
 
 
By applying single molecule pull down (SiMPull) of four human cell expressed 
double strand RNA binding proteins (dsRBPs) and measurement of the interaction between 
dsRBPs and various dsRNAs, our results showed that  the four tested dsRBPs exhibit different 
substrate specificities on our single molecule platform. Specifically, TRBP and ADAR1 have a 
preference for binding simple duplex RNA, while ADAD2 and Staufen1 display higher affinity 
to imperfectly base-paired structured RNA substrates, containing loop, bulge and mismatches. 
Furthermore, RNA binding affinity of dsRBP does not seem to depend on the number of its 
dsRBD-I. This showed an example of how single molecule approaches could be utilized to 
provide new insight into molecular mechanisms involved in protein-RNA interaction. 
Collectively, our study highlights the diverse nature of substrate specificity exhibited by dsRBPs 
that may be critical for their cellular function. 
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